Compile Data Set for Download or QSAR

Found 1151 hits of ec50 for UniProtKB: P03952   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Plasma kallikrein (Homo sapiens (Human))	BDBM454849 (US10730874, Compound I-147 | US10730874, Compound ...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454966 (US10730874, Compound I-5 | US11352356, Compound I-...) Show SMILES Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C23H20BrN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454984 (US10730874, Compound I-8 | US11352356, Compound I-...) Show SMILES CC(C)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1 Show InChI InChI=1S/C23H22ClN7O/c1-15(2)16-3-4-22-28-19(12-30(22)10-16)13-31-11-17(8-27-31)23(32)25-9-20-21-7-18(24)5-6-29(21)14-26-20/h3-8,10-12,14-15H,9,13H2,1-2H3,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454986 (US10730874, Compound I-10 | US11352356, Compound I...) Show SMILES CC1(CC1)c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1 Show InChI InChI=1S/C24H22ClN7O/c1-24(5-6-24)17-2-3-22-29-19(13-31(22)12-17)14-32-11-16(9-28-32)23(33)26-10-20-21-8-18(25)4-7-30(21)15-27-20/h2-4,7-9,11-13,15H,5-6,10,14H2,1H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454989 (US10730874, Compound I-13 | US11352356, Compound I...) Show SMILES Cc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1 Show InChI InChI=1S/C24H22ClN7O/c1-15-20(16-2-3-16)4-5-23-29-19(13-32(15)23)12-31-11-17(9-28-31)24(33)26-10-21-22-8-18(25)6-7-30(22)14-27-21/h4-9,11,13-14,16H,2-3,10,12H2,1H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454990 (US10730874, Compound I-14 | US11352356, Compound I...) Show SMILES Cc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1 Show InChI InChI=1S/C24H22BrN7O/c1-15-20(16-2-3-16)4-5-23-29-19(13-32(15)23)12-31-11-17(9-28-31)24(33)26-10-21-22-8-18(25)6-7-30(22)14-27-21/h4-9,11,13-14,16H,2-3,10,12H2,1H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454991 (US10730874, Compound I-15 | US11352356, Compound I...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-19(20(29)7-16)9-24-22(32)15-8-26-30(10-15)11-17-12-31-21(27-17)4-3-18(28-31)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,24,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454999 (US10730874, Compound I-23 | US11352356, Compound I...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5c(Cl)c(ccc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C23H19Cl2N7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455007 (US10730874, Compound I-31 | US10730874, Compound I...) Show SMILES COCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12 Show InChI InChI=1S/C25H24ClN7O2/c1-35-14-22-20(25(34)27-9-21-23-8-18(26)6-7-31(23)15-28-21)13-33(30-22)12-19-11-32-10-17(16-2-3-16)4-5-24(32)29-19/h4-8,10-11,13,15-16H,2-3,9,12,14H2,1H3,(H,27,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455016 (US10730874, Compound I-40 | US11352356, Compound I...) Show SMILES Clc1c(Br)ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12 Show InChI InChI=1S/C20H14Br2ClN7O/c21-13-3-4-28-11-25-16(17(28)5-13)7-24-20(31)12-6-26-29(8-12)9-14-10-30-18(27-14)2-1-15(22)19(30)23/h1-6,8,10-11H,7,9H2,(H,24,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455019 (US10730874, Compound I-43 | US11352356, Compound I...) Show SMILES CC1CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn2c1 Show InChI InChI=1S/C24H22ClN7O/c1-15-6-20(15)16-2-3-23-29-19(12-31(23)10-16)13-32-11-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h2-5,7-8,10-12,14-15,20H,6,9,13H2,1H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455020 (US10730874, Compound I-44 | US11352356, Compound I...) Show SMILES CC1CC1c1ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn2c1 Show InChI InChI=1S/C24H22BrN7O/c1-15-6-20(15)16-2-3-23-29-19(12-31(23)10-16)13-32-11-17(8-28-32)24(33)26-9-21-22-7-18(25)4-5-30(22)14-27-21/h2-5,7-8,10-12,14-15,20H,6,9,13H2,1H3,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455026 (US10730874, Compound I-50 | US10730874, Compound I...) Show SMILES Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cc5cc(ccn5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C23H20BrN7O/c24-18-4-5-29-14-26-21(22(29)8-18)11-25-23(32)17-10-27-30(12-17)13-19-9-20-7-16(15-1-2-15)3-6-31(20)28-19/h3-10,12,14-15H,1-2,11,13H2,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455027 (US10730874, Compound I-51 | US11352356, Compound I...) Show SMILES Clc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c2c1 Show InChI InChI=1S/C22H18ClN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455028 (US10730874, Compound I-52 | US11352356, Compound I...) Show SMILES Brc1ccn2cnc(CNC(=O)c3nnc(Cc4cn5cc(ccc5n4)C4CC4)o3)c2c1 Show InChI InChI=1S/C22H18BrN7O2/c23-15-5-6-29-12-25-17(18(29)7-15)9-24-21(31)22-28-27-20(32-22)8-16-11-30-10-14(13-1-2-13)3-4-19(30)26-16/h3-7,10-13H,1-2,8-9H2,(H,24,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455033 (US10730874, Compound I-57 | US11352356, Compound I...) Show SMILES Clc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1 Show InChI InChI=1S/C23H19BrClN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455035 (US10730874, Compound I-59 | US11352356, Compound I...) Show SMILES Fc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)cn12)C1CC1 Show InChI InChI=1S/C23H19ClFN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455036 (US10730874, Compound I-60 | US11352356, Compound I...) Show SMILES Fc1c(ccc2nc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)cc34)cn12)C1CC1 Show InChI InChI=1S/C23H19BrFN7O/c24-16-5-6-30-13-27-19(20(30)7-16)9-26-23(33)15-8-28-31(10-15)11-17-12-32-21(29-17)4-3-18(22(32)25)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455041 (US10730874, Compound I-65 | US11352356, Compound I...) Show SMILES COC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12 Show InChI InChI=1S/C27H26ClN7O3/c1-38-26(36)7-5-22-21(27(37)29-11-23-24-10-19(28)8-9-33(24)16-30-23)15-35(32-22)14-20-13-34-12-18(17-2-3-17)4-6-25(34)31-20/h4,6,8-10,12-13,15-17H,2-3,5,7,11,14H2,1H3,(H,29,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455042 (US10730874, Compound I-66 | US11352356, Compound I...) Show SMILES O=C(NCc1ncn2ccc(cc12)C#C)c1cnn(Cc2cn3cc(ccc3n2)C2CC2)c1 Show InChI InChI=1S/C25H21N7O/c1-2-17-7-8-30-16-27-22(23(30)9-17)11-26-25(33)20-10-28-32(13-20)15-21-14-31-12-19(18-3-4-18)5-6-24(31)29-21/h1,5-10,12-14,16,18H,3-4,11,15H2,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455044 (US10730874, Compound I-68 | US11352356, Compound I...) Show SMILES Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C22H19BrN8O/c23-16-5-6-29-13-25-19(20(29)7-16)9-24-22(32)15-8-26-30(10-15)11-17-12-31-21(27-17)4-3-18(28-31)14-1-2-14/h3-8,10,12-14H,1-2,9,11H2,(H,24,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455047 (US10730874, Compound I-104a | US10730874, Compound...) Show SMILES CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455049 (US10730874, Compound I-73 | US11352356, Compound I...) Show SMILES OC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12 Show InChI InChI=1S/C26H24ClN7O3/c27-18-7-8-32-15-29-22(23(32)9-18)10-28-26(37)20-14-34(31-21(20)4-6-25(35)36)13-19-12-33-11-17(16-1-2-16)3-5-24(33)30-19/h3,5,7-9,11-12,14-16H,1-2,4,6,10,13H2,(H,28,37)(H,35,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455051 (US10730874, Compound I-75 | US11352356, Compound I...) Show SMILES OCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455052 (US10730874, Compound I-76) Show SMILES Brc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cnc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C22H19BrN8O/c23-17-3-4-29-13-26-19(20(29)5-17)8-24-21(32)16-7-27-31(10-16)12-18-11-30-9-15(14-1-2-14)6-25-22(30)28-18/h3-7,9-11,13-14H,1-2,8,12H2,(H,24,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455054 (US10730874, Compound I-78 | US11352356, Compound I...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3CC3)c2c1 Show InChI InChI=1S/C26H24ClN7O/c27-19-7-8-32-15-29-22(23(32)9-19)10-28-26(35)21-14-34(31-25(21)17-3-4-17)13-20-12-33-11-18(16-1-2-16)5-6-24(33)30-20/h5-9,11-12,14-17H,1-4,10,13H2,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455056 (US10730874, Compound I-80 | US11352356, Compound I...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nn3)c2c1 Show InChI InChI=1S/C22H19ClN8O/c23-16-5-6-29-13-25-18(20(29)7-16)8-24-22(32)19-12-31(28-27-19)11-17-10-30-9-15(14-1-2-14)3-4-21(30)26-17/h3-7,9-10,12-14H,1-2,8,11H2,(H,24,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455057 (US10730874, Compound I-81 | US11352356, Compound I...) Show SMILES COC(=O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C26H24ClN7O3/c1-37-24(35)7-17-6-18(16-2-3-16)11-33-13-21(31-25(17)33)14-34-12-19(9-30-34)26(36)28-10-22-23-8-20(27)4-5-32(23)15-29-22/h4-6,8-9,11-13,15-16H,2-3,7,10,14H2,1H3,(H,28,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455061 (US10730874, Compound I-85 | US11352356, Compound I...) Show SMILES Brc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3CC3)c2c1 Show InChI InChI=1S/C26H24BrN7O/c27-19-7-8-32-15-29-22(23(32)9-19)10-28-26(35)21-14-34(31-25(21)17-3-4-17)13-20-12-33-11-18(16-1-2-16)5-6-24(33)30-20/h5-9,11-12,14-17H,1-4,10,13H2,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455062 (US10730874, Compound I-86) Show SMILES OC(=O)Cc1cc(cn2cc(Cn3cc(C(=O)NCc4ncn5ccc(Cl)cc45)c(n3)C3CC3)nc12)C1CC1 Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455063 (US10730874, Compound I-87) Show SMILES OCCc1cc(cn2cc(Cn3cc(C(=O)NCc4ncn5ccc(Cl)cc45)c(n3)C3CC3)nc12)C1CC1 Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM454849 (US10730874, Compound I-147 | US10730874, Compound ...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C23H20ClN7O/c24-18-5-6-29-14-26-20(21(29)7-18)9-25-23(32)17-8-27-31(11-17)13-19-12-30-10-16(15-1-2-15)3-4-22(30)28-19/h3-8,10-12,14-15H,1-2,9,13H2,(H,25,32)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455068 (US10730874, Compound I-92 | US11352356, Compound I...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(C#N)c5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C24H19ClN8O/c25-19-3-4-31-14-28-21(22(31)6-19)9-27-24(34)18-8-29-33(11-18)13-20-12-32-10-17(15-1-2-15)5-16(7-26)23(32)30-20/h3-6,8,10-12,14-15H,1-2,9,13H2,(H,27,34)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455069 (US10730874, Compound I-93 | US11352356, Compound I...) Show SMILES CCOC(=O)CCc1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12 Show InChI InChI=1S/C28H28ClN7O3/c1-2-39-27(37)8-6-23-22(28(38)30-12-24-25-11-20(29)9-10-34(25)17-31-24)16-36(33-23)15-21-14-35-13-19(18-3-4-18)5-7-26(35)32-21/h5,7,9-11,13-14,16-18H,2-4,6,8,12,15H2,1H3,(H,30,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455073 (US10730874, Compound I-97 | US11352356, Compound I...) Show SMILES Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(ccc5n4)C4CC4)c3)c12 Show InChI InChI=1S/C23H19BrFN7O/c24-18-5-6-30-13-27-19(22(30)21(18)25)8-26-23(33)16-7-28-32(10-16)12-17-11-31-9-15(14-1-2-14)3-4-20(31)29-17/h3-7,9-11,13-14H,1-2,8,12H2,(H,26,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455074 (US10730874, Compound I-98 | US11352356, Compound I...) Show SMILES O=C(NCc1ncn2ccc(cc12)C#C)c1cnn(Cc2cn3nc(ccc3n2)C2CC2)c1 Show InChI InChI=1S/C24H20N8O/c1-2-16-7-8-30-15-26-21(22(30)9-16)11-25-24(33)18-10-27-31(12-18)13-19-14-32-23(28-19)6-5-20(29-32)17-3-4-17/h1,5-10,12,14-15,17H,3-4,11,13H2,(H,25,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455075 (US10730874, Compound I-99 | US11352356, Compound I...) Show SMILES FC(F)c1nn(Cc2cn3cc(ccc3n2)C2CC2)cc1C(=O)NCc1ncn2ccc(Cl)cc12 Show InChI InChI=1S/C24H20ClF2N7O/c25-16-5-6-32-13-29-19(20(32)7-16)8-28-24(35)18-12-34(31-22(18)23(26)27)11-17-10-33-9-15(14-1-2-14)3-4-21(33)30-17/h3-7,9-10,12-14,23H,1-2,8,11H2,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455076 (US10730874, Compound I-100a | US10730874, Compound...) Show SMILES COC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C27H24ClN7O3/c1-38-25(36)5-4-18-8-19(17-2-3-17)12-34-14-22(32-26(18)34)15-35-13-20(10-31-35)27(37)29-11-23-24-9-21(28)6-7-33(24)16-30-23/h4-10,12-14,16-17H,2-3,11,15H2,1H3,(H,29,37)/b5-4+	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455076 (US10730874, Compound I-100a | US10730874, Compound...) Show SMILES COC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C27H24ClN7O3/c1-38-25(36)5-4-18-8-19(17-2-3-17)12-34-14-22(32-26(18)34)15-35-13-20(10-31-35)27(37)29-11-23-24-9-21(28)6-7-33(24)16-30-23/h4-10,12-14,16-17H,2-3,11,15H2,1H3,(H,29,37)/b5-4+	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455076 (US10730874, Compound I-100a | US10730874, Compound...) Show SMILES COC(=O)\C=C\c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C27H24ClN7O3/c1-38-25(36)5-4-18-8-19(17-2-3-17)12-34-14-22(32-26(18)34)15-35-13-20(10-31-35)27(37)29-11-23-24-9-21(28)6-7-33(24)16-30-23/h4-10,12-14,16-17H,2-3,11,15H2,1H3,(H,29,37)/b5-4+	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455079 (US10730874, Compound I-101 | US11352356, Compound ...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cnn(Cc4cn5cc(cc(CN6CCOCC6)c5n4)C4CC4)c3)c2c1 Show InChI InChI=1S/C28H29ClN8O2/c29-23-3-4-35-18-31-25(26(35)10-23)12-30-28(38)22-11-32-37(15-22)17-24-16-36-14-20(19-1-2-19)9-21(27(36)33-24)13-34-5-7-39-8-6-34/h3-4,9-11,14-16,18-19H,1-2,5-8,12-13,17H2,(H,30,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455080 (US10730874, Compound I-102 | US11352356, Compound ...) Show SMILES Clc1ccn2cnc(CNC(=O)c3cn(Cc4cn5cc(ccc5n4)C4CC4)nc3C3COC3)c2c1 Show InChI InChI=1S/C26H24ClN7O2/c27-19-5-6-32-15-29-22(23(32)7-19)8-28-26(35)21-12-34(31-25(21)18-13-36-14-18)11-20-10-33-9-17(16-1-2-16)3-4-24(33)30-20/h3-7,9-10,12,15-16,18H,1-2,8,11,13-14H2,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455081 (US10730874, Compound I-103 | US11352356, Compound ...) Show SMILES COCCOc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C26H26ClN7O3/c1-36-6-7-37-24-8-18(17-2-3-17)12-33-14-21(31-25(24)33)15-34-13-19(10-30-34)26(35)28-11-22-23-9-20(27)4-5-32(23)16-29-22/h4-5,8-10,12-14,16-17H,2-3,6-7,11,15H2,1H3,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455047 (US10730874, Compound I-104a | US10730874, Compound...) Show SMILES CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455047 (US10730874, Compound I-104a | US10730874, Compound...) Show SMILES CCOC(=O)c1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C26H24ClN7O3/c1-2-37-26(36)21-7-17(16-3-4-16)11-33-13-20(31-24(21)33)14-34-12-18(9-30-34)25(35)28-10-22-23-8-19(27)5-6-32(23)15-29-22/h5-9,11-13,15-16H,2-4,10,14H2,1H3,(H,28,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455084 (US10730874, Compound I-105 | US11352356, Compound ...) Show SMILES CCCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)c(F)c34)nc12)C1CC1 Show InChI InChI=1S/C26H25BrFN7O/c1-2-3-17-8-18(16-4-5-16)11-34-13-20(32-25(17)34)14-35-12-19(9-31-35)26(36)29-10-22-24-23(28)21(27)6-7-33(24)15-30-22/h6-9,11-13,15-16H,2-5,10,14H2,1H3,(H,29,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455085 (US10730874, Compound I-106) Show SMILES OC(=O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Br)c(F)c34)nc12)C1CC1 Show InChI InChI=1S/C25H21BrFN7O3/c26-20-3-4-32-13-29-21(23(32)22(20)27)7-28-25(36)18-6-30-34(9-18)11-19-10-33-8-16(15-1-2-15)5-17(12-37-14-35)24(33)31-19/h3-6,8-10,13-15H,1-2,7,11-12H2,(H,28,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455086 (US10730874, Compound I-107 | US11352356, Compound ...) Show SMILES OCCCc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C28H28ClN7O3/c1-2-39-26(37)6-5-19-9-20(18-3-4-18)13-35-15-23(33-27(19)35)16-36-14-21(11-32-36)28(38)30-12-24-25-10-22(29)7-8-34(25)17-31-24/h7-11,13-15,17-18H,2-6,12,16H2,1H3,(H,30,38)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455087 (US10730874, Compound I-108 | US11352356, Compound ...) Show SMILES Fc1c(Br)ccn2cnc(CNC(=O)c3cnn(Cc4cn5nc(ccc5n4)C4CC4)c3)c12 Show InChI InChI=1S/C22H18BrFN8O/c23-16-5-6-30-12-26-18(21(30)20(16)24)8-25-22(33)14-7-27-31(9-14)10-15-11-32-19(28-15)4-3-17(29-32)13-1-2-13/h3-7,9,11-13H,1-2,8,10H2,(H,25,33)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM455088 (US10730874, Compound I-109 | US11352356, Compound ...) Show SMILES CC(C)(O)Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)cc34)nc12)C1CC1 Show InChI InChI=1S/C27H28ClN7O2/c1-27(2,37)9-18-7-19(17-3-4-17)12-34-14-22(32-25(18)34)15-35-13-20(10-31-35)26(36)29-11-23-24-8-21(28)5-6-33(24)16-30-23/h5-8,10,12-14,16-17,37H,3-4,9,11,15H2,1-2H3,(H,29,36)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	<1	n/a	n/a	n/a	n/a
Shire Human Genetic Therapies, Inc. US Patent					Assay Description Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...				US Patent US10730874 (2020) BindingDB Entry DOI: 10.7270/Q2RN3BXC
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1151 total )  |  Next  |  Last  >>

Jump to: